Effect of Bone Morphogenetic Protein-2 Combined With Microfracture for Osteochondral Defect of the Talus in a Rabbit Model

被引:4
|
作者
Dang, Le Hoang Nam [1 ]
Tran, Nhat Tien [2 ,3 ]
Oh, Jong-Sung [2 ]
Kwon, Tae-Young [2 ,4 ]
Lee, Kwang-Bok [2 ,4 ]
机构
[1] Hue Univ, Hue Univ Med & Pharm, Dept Anat Surg Training, Hue, Vietnam
[2] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Biomed Res Inst, Med Sch,Res Inst Clin Med,Dept Orthoped Surg, Jeonju, South Korea
[3] Hue Univ, Hue Univ Med & Pharm, Dept Surg, Hue, Vietnam
[4] Jeonbuk Natl Univ Hosp, Dept Orthoped Surg, Jeonju 63418, Jeonbuk, South Korea
来源
AMERICAN JOURNAL OF SPORTS MEDICINE | 2023年 / 51卷 / 06期
关键词
rhBMP-2; hydroxyapatite; microfracture; osteochondral defect; talus; ARTICULAR-CARTILAGE DEFECTS; FULL-THICKNESS DEFECTS; ARTHROSCOPIC TREATMENT; GROWTH-FACTORS; LESIONS; CHONDROGENESIS; HYDROXYAPATITE; HEPARIN; MATRIX; REGENERATION;
D O I
10.1177/03635465231162316
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Osteochondral defects of the talus can be effectively treated using microfracture, which is technically safe, accessible, and affordable. However, fibrous tissue and fibrocartilage comprise the majority of tissue repairs resulting from these procedures. These tissue types lack the mechanical characteristics of native hyaline cartilage and might significantly contribute to the decline in long-term outcomes. Recombinant human-bone morphogenetic protein-2 (rhBMP-2) has been shown to promote matrix synthesis and increase cartilage formation, thus enhancing chondrogenesis in vitro. Purpose: This study aimed to evaluate the treatment ability of combining rhBMP-2 with microfracture in rabbit talus osteochondral defect. Study Design: Controlled laboratory study. Methods: A full-thickness chondral defect (3 x 3 x 2 mm) was constructed in the center talar dome of 24 New Zealand White male rabbits, which were then divided into 4 groups of 6. Each group received the appropriate treatment: group 1 (control; no treatment of defect), group 2 (microfracture treatment), group 3 (rhBMP-2/hydroxyapatite treatment), and group 4 (microfracture combined with rhBMP-2/hydroxyapatite treatment). Animals were sacrificed at 2, 4, and 6 weeks postoperatively. The International Cartilage Regeneration & Joint Preservation Society macroscopic score, which considers the degree of defect repair, the integration to the border zone, and the macroscopic appearance, was used to assess the repaired tissue's macroscopic appearance. Subchondral bone regeneration in defects was analyzed using micro-computed tomography, and the histological findings were graded using a modified version of the Wakitani scoring system for osteochondral repair. Results: At 2, 4, and 6 weeks, micro-computed tomography analysis revealed that groups 3 and 4 exhibited subchondral bone healing that was more significantly improved compared with groups 1. No sample showed excessive bone growth from the subchondral bone area. According to macroscopic and histological results, group 4 showed higher-quality cartilage and more accelerated cartilage regeneration than the other groups over time. Conclusion: These findings show that osteochondral defect repair in a rabbit talus model could be effectively accelerated and improved by combining rhBMP-2 with microfracture.
引用
收藏
页码:1560 / 1570
页数:11
相关论文
共 50 条
  • [41] Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) : 317 - 321
  • [42] Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling
    Higuchi, T
    Kinoshita, A
    Takahashi, K
    Oda, S
    Ishikawa, I
    JOURNAL OF PERIODONTOLOGY, 1999, 70 (09) : 1026 - 1031
  • [43] Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    CLINICAL ORAL IMPLANTS RESEARCH, 2002, 13 (01) : 80 - 85
  • [44] Application of combined porous tantalum scaffolds loaded with bone morphogenetic protein 7 to repair of osteochondral defect in rabbits*
    Qian Wang
    Hui Zhang
    Hongquan Gan
    Hui Wang
    Qijia Li
    Zhiqiang Wang
    International Orthopaedics, 2018, 42 : 1437 - 1448
  • [45] Application of combined porous tantalum scaffolds loaded with bone morphogenetic protein 7 to repair of osteochondral defect in rabbits
    Wang, Qian
    Zhang, Hui
    Gan, Hongquan
    Wang, Hui
    Li, Qijia
    Wang, Zhiqiang
    INTERNATIONAL ORTHOPAEDICS, 2018, 42 (07) : 1437 - 1448
  • [46] Improving Bone Formation in a Rat Femur Segmental Defect by Controlling Bone Morphogenetic Protein-2 Release
    Brown, Kate V.
    Li, Bing
    Guda, Teja
    Perrien, Daniel S.
    Guelcher, Scott A.
    Wenke, Joseph C.
    TISSUE ENGINEERING PART A, 2011, 17 (13-14) : 1735 - 1746
  • [47] The Effect of the Delivery Carrier on the Quality of Bone Formed via Bone Morphogenetic Protein-2
    La, Wan-Geun
    Kwon, Sun-Hyun
    Lee, Tae-Jin
    Yang, Hee Seok
    Park, Jooyeon
    Kim, Byung-Soo
    ARTIFICIAL ORGANS, 2012, 36 (07) : 642 - 647
  • [48] The Effect of NELL1 and Bone Morphogenetic Protein-2 on Calvarial Bone Regeneration
    Aghaloo, Tara
    Cowan, Catherine M.
    Zhang, Xinli
    Freymiller, Earl
    Soo, Chia
    Wu, Benjamin
    Ting, Kang
    Zhang, Zhiyuan
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (02) : 300 - 308
  • [49] Effect of hyperbaric oxygenation on bone induced by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2001, 39 (02): : 91 - 95
  • [50] Effect of Bone Morphogenetic Protein-2 in the Treatment of Long Bone Non-Unions
    Fuchs, Thomas
    Stolberg-Stolberg, Josef
    Michel, Philipp A.
    Garcia, Patric
    Amler, Susanne
    Wahnert, Dirk
    Raschke, Michael J.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)